Structures by: Buchanan R. M.
Total: 31
N-(2-((2-mercaptoethyl)amino)ethyl)-1-methyl-1H-imidazole -2-carboxamido nickel(II)
C9H14N4NiOS,H2O
CrystEngComm (2018) 20, 44 7071
a=11.9515(15)Å b=4.8375(6)Å c=22.198(3)Å
α=90.00° β=103.424(2)° γ=90.00°
Bis-(N-(2-aminoethyl)-1-methyl-1H-imidazole-2-carboxamido) nickel(II)
C14H22N8NiO2,H2O
CrystEngComm (2018) 20, 44 7071
a=9.1756(19)Å b=10.590(2)Å c=9.4434(19)Å
α=90.00° β=98.876(3)° γ=90.00°
1-methyl-N-(2-((4-oxopentan-2-ylidene)amino)ethyl)-1H-imidazole-2-carboxamido nickel(II)
C12H16N4NiO2,3(H2O)
CrystEngComm (2018) 20, 44 7071
a=6.8975(18)Å b=9.130(2)Å c=12.645(3)Å
α=92.821(4)° β=92.276(4)° γ=104.339(4)°
1-methyl-(methyl-(3-(2-ethyl)imino)butanoate) -1H-imidazole-2-carboxamido nickel(II)
C12H16N4NiO3,H2O
CrystEngComm (2018) 20, 44 7071
a=9.2792(6)Å b=13.6005(8)Å c=21.7240(13)Å
α=90.00° β=95.3700(10)° γ=90.00°
L3-Cu[ClO4]2
C12H20Cl2CuN6O8
Dalton transactions (Cambridge, England : 2003) (2016) 45, 45 18356-18364
a=17.244(2)Å b=8.1023(10)Å c=13.7251(15)Å
α=90.00° β=96.258(12)° γ=90.00°
[HL3-Cu(CH3CN)2][ClO4]3
C16H27CuN8,3(ClO4),C2H3N
Dalton transactions (Cambridge, England : 2003) (2016) 45, 45 18356-18364
a=23.0000(5)Å b=8.71951(15)Å c=30.2613(6)Å
α=90.00° β=92.295(2)° γ=90.00°
[L1Cu(OClO3)]ClO4
C14H19ClCuN7O4,ClO4
Dalton transactions (Cambridge, England : 2003) (2016) 45, 40 15791-15799
a=8.7479(8)Å b=10.1421(7)Å c=12.9690(10)Å
α=68.941(7)° β=75.950(7)° γ=88.025(7)°
[L1Cu(OH2)]ClO4
C12H18ClCuN6O5,ClO4
Dalton transactions (Cambridge, England : 2003) (2016) 45, 40 15791-15799
a=8.227(3)Å b=11.003(4)Å c=11.441(4)Å
α=78.99(3)° β=70.69(3)° γ=88.76(3)°
[L2Cu(HOCH3)][O3SCF3]2
C15H24CuF3N6O5S,CF3O3S,0.67(H2O)
Dalton transactions (Cambridge, England : 2003) (2016) 45, 40 15791-15799
a=8.30645(16)Å b=12.6697(2)Å c=13.6657(2)Å
α=93.3069(14)° β=103.0089(16)° γ=107.1032(17)°
[L2Cu(HOCH3)][BF4]2
C14H24CuN6O2,2(BF4)
Dalton transactions (Cambridge, England : 2003) (2016) 45, 40 15791-15799
a=7.83639(13)Å b=11.5417(3)Å c=12.5358(3)Å
α=88.3240(19)° β=73.9097(18)° γ=82.5500(16)°
L1
C12H16N6,H2O
Dalton transactions (Cambridge, England : 2003) (2016) 45, 40 15791-15799
a=9.37814(17)Å b=12.2120(2)Å c=11.9164(2)Å
α=90.00° β=95.9045(16)° γ=90.00°
Ethyl 1-methyimidazole-2-carboxylate
C7H10N2O2
Acta Crystallographica Section E (2006) 62, 4 o1548-o1549
a=7.1040(8)Å b=15.2244(18)Å c=7.4511(9)Å
α=90.00° β=112.797(2)° γ=90.00°
C31H38Fe2N6O6
C31H38Fe2N6O6
Acta Crystallographica Section C (1991) 47, 11 2307-2310
a=13.601(3)Å b=13.966(3)Å c=12.341(3)Å
α=100.10(2)° β=99.56(2)° γ=115.19(2)°
C14H21Cl2CuN7O8
C14H21Cl2CuN7O8
Acta Crystallographica Section C (1991) 47, 10 2037-2040
a=9.1710(10)Å b=8.9990(10)Å c=26.677(3)Å
α=90° β=94.080(10)° γ=90°
C17H19ClCuF6N5P
C17H19ClCuF6N5P
Acta Crystallographica Section C (1995) 51, 1 50-52
a=14.235(3)Å b=11.368(3)Å c=13.860(3)Å
α=90° β=108.84(2)° γ=90°
(1,4-Dioxan-2-yl)diphenylmethanol
C17H18O3
Acta Crystallographica Section C (2011) 67, 4 o129-o130
a=12.9108(8)Å b=10.5408(5)Å c=10.3022(7)Å
α=90.00° β=94.016(6)° γ=90.00°
Tmima boric acid
C15H21N7,B(HO)3
Acta Crystallographica Section C (2002) 58, 10 o629-o631
a=16.2812(17)Å b=10.0010(10)Å c=12.2564(13)Å
α=90° β=110.72(2)° γ=90°
5,10-dihyhydroxy-5H,10H-diimidazo[1,2-a:1',2'-d]pyrazine
C8H8N4O2
Acta Crystallographica Section C (2005) 61, 6 o361-o362
a=6.6274(19)Å b=3.9625(11)Å c=15.260(4)Å
α=90.00° β=100.615(5)° γ=90.00°
Tetra-μ-acetato-κ^8^<i>O</i>:<i>O</i>-bis{[2,2-dimethyl-<i>N</i>-(pyridin-2-yl)propanamide-κ<i>N</i>^1^]copper(II)}(<i>Cu</i>—–-<i>Cu</i>)
C28H40Cu2N4O10
Acta Crystallographica Section E (2011) 67, 12 m1892-m1893
a=13.8508(8)Å b=11.0612(5)Å c=11.0301(6)Å
α=90.00° β=104.508(6)° γ=90.00°
[Cu(L2)OH]ClO4
C25H40N9CuO3,ClO4
Inorganic chemistry (2006) 45, 8 3191-3202
a=21.653(10)Å b=10.260(5)Å c=31.194(15)Å
α=90.00° β=93.766(8)° γ=90.00°
[Cu(L2)Cl]ClO4
C25H39CuN9ClO2,ClO4
Inorganic chemistry (2006) 45, 8 3191-3202
a=18.908(9)Å b=20.140(9)Å c=11.196(5)Å
α=90.00° β=94.606(8)° γ=90.00°
L2
C25H39N9O2,H2O
Inorganic chemistry (2006) 45, 8 3191-3202
a=29.757(6)Å b=11.358(2)Å c=19.493(4)Å
α=90.00° β=97.948(3)° γ=90.00°
(N-{2-[(2-mercapto-2-methylpropyl)amino]ethyl}- 1-methylimidazole-2-carboxamido)nickel(II)
C11H18N4NiOS,H2O
Inorganic Chemistry (2009) 48, 9974-9976
a=24.166(11)Å b=5.302(3)Å c=11.363(5)Å
α=90.00° β=97.407(7)° γ=90.00°
(N-{2-[(2-sulfinyl-2-methylpropyl)amino]ethyl}-1- methylimidazole-2-carboxamido)nickel(II)
C11H18N4NiO3S
Inorganic Chemistry (2009) 48, 9974-9976
a=6.0103(9)Å b=10.1562(15)Å c=23.342(4)Å
α=90.00° β=90.00° γ=90.00°
Dichloro(4-((1-methyl-1H-imidazol-2-yl)methyl)- 1-thia-4,7-diazacyclononane)iron(III) tetrachloroferrate(III)
C11H20Cl2FeN4S,Cl4Fe
Inorganic Chemistry (2010) 49, 10427-10435
a=13.0605(6)Å b=10.4331(5)Å c=16.1935(7)Å
α=90.00° β=110.2420(10)° γ=90.00°
Dichloro(4-((1-methyl-1H-imidazol-2-yl)methyl)- 1-thia-4,7-diazacyclononane)iron(III) hexafluorophosphate
C11H20Cl2FeN4S,F6P
Inorganic Chemistry (2010) 49, 10427-10435
a=7.6275(8)Å b=14.4722(15)Å c=16.9469(17)Å
α=90.00° β=93.766(2)° γ=90.00°
Mu-oxo-bis(chloro(4-((1-methyl-1H-imidazol-2-yl)methyl)- 1-thia-4,7-diazacyclononane)iron(III)) hexafluorophosphate
C22H40Cl2Fe2N8OS2,F6P,Cl
Inorganic Chemistry (2010) 49, 10427-10435
a=8.7061(4)Å b=16.0693(8)Å c=23.5679(12)Å
α=90.00° β=90.00° γ=90.00°
C23H34Cl4Fe2N7O2
C23H34Cl4Fe2N7O2
Inorganic Chemistry (1996) 35, 6642-6643
a=14.228(3)Å b=18.386(4)Å c=13.085(2)Å
α=90° β=90° γ=90°
C38H57Cl3Fe2N14O15
C38H57Cl3Fe2N14O15
Inorganic Chemistry (1996) 35, 6642-6643
a=21.581(6)Å b=24.030(7)Å c=10.137(3)Å
α=90° β=90° γ=90°
[L2Cu(HOCH3)][ClO4]2
C14H24ClCuN6O6,ClO4
Dalton transactions (Cambridge, England : 2003) (2016) 45, 40 15791-15799
a=13.0049(3)Å b=11.5913(2)Å c=15.1039(4)Å
α=90.00° β=104.371(3)° γ=90.00°
[Cu(L2)N3]ClO4
C25H39CuN12O2,ClO4
Inorganic chemistry (2006) 45, 8 3191-3202
a=12.003(3)Å b=12.133(3)Å c=13.327(3)Å
α=116.114(4)° β=103.539(4)° γ=99.520(4)°